We have observed
5 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after February 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Compressed oral dosage form for asenapine maleate
Process for the preparation of form III of Vilazodone hydrochloride
Crystalline form of mastinib mesylate
Dosage form comprising a pressure sensitive solid form of an active pharmaceutical ingredient
AMORPHOUS AND CRYSTALLINE FORMS OF IDELALISIB AND PROCESS FOR FORMING THE SAME